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• Assessment of treatment response 
and progression is suboptimal in 
glioblastoma (GBM).  
• In the context of pseudo-progression, 
radiographic change is a challenging 
parameter to assess.  
• Based on unpublished data from 
Gzell et. al., a novel method for 
measurement of contrast 
enhancement demonstrates promise 
in predicting survival.   
• We aim to determine if early 
measurement of radiographic change 
post-CRT using  multiple methods is 
predictive for overall survival (OS) 
and progression free survival (PFS).  
Purpose/Objectives Techniques 
 
• Patients with primary GBM who 
received CRT between 2007-14 and 
had sequential post-CRT gadolium-
enhanced T1 weighted (T1+C) MRIs 
post-operatively, at 1 month, and 3 
months within our PACS were 
identified.  
• Inclusion criteria for analysis: 
initiation of concurrent CRT, 
presence of 1 and 3 month post-CRT 
T1+C MRIs, absence of clinical or 
radiographic progression by 3 
months post-CRT, and no treatment 
with bevacuzimab prior to 3 months 
post-CRT.  
• 29/97 eligible patients T+1 C MRIs 
were subsequently imported into 
Pinnacle for analysis.  
• We quantified bi-directional product 
(BP),  volume of the post-surgical 
cavity including surrounding 
enhancement (Vol),  and volume of 
T1+C enhanced rim (Rim) with the 
cavity subtracted.  
• We sought to determine if increases 
of 5% and/or 25% between PO and 
1 or 3 month T1+C MRI’s were 
predictive of worse OS and PFS for 
each technique.  
 
Results 
 
Conclusions 
• Even minor change in the relative amount of 
enhancement surrounding the post-surgical cavity 
is an early prognostic factor for OS and PFS.  
Changes of Vol or BP were not significant 
predictors of OS. These findings suggest that 
either a lack of early response or 
underappreciated progression portends a 
significantly worse prognosis and raises the 
question of whether salvage therapies should be 
considered earlier in these patients.  
1The George Washington University School of Medicine, Washington, D.C., 2University of Maryland School of Medicine, Baltimore, 
MD, 3Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, Australia 
Minimal Increase in contrast enhancement after chemo-radiotherapy (CRT) for 
glioblastoma predicts worse survival and progression-free survival  
Sameer Aggarwal1, Jason Molitoris2, Cecelia Gzell3, Minesh Mehta2 
Figure 3: 1 Month RIM +/- 
5% OS  
 
 
Methods 
RIM <5% >5% P1 <25% >25% P2 
M+1 26.9  15.23 0.010 26.9 13.87 0.001 
M+3 26.9 16.77 0.016 31.3 15.23 0.001 
Table 1: Overall Survival (Months)  
Figure 5: Volumetric Technique  
Figure 6: Rim Technique  
Post-operative post-CRT T1 + C MRI. Volumetric technique  
contours surgical resection cavity. (highlighted in RED).    
Post-operative post-CRT T1+ C MRI. Rim technique  
contours contrast enhancement (highlighted in GREEN).  
Figure 7: BP Technique  
Post-operative post-CRT T1+ C MRI. BP technique 
marks  measures volume cavity with the largest x and 
y axis.  
Figure 1: 3 Month  
RIM +/-25% OS 
RIM < 5% >5% P1 <25% >25% P2 
M+1 12.0 14.9 0.127 14.93 11.70 0.015 
M+3 12.2 9.33 0.203 15.50 10.030 0.011 
Table 2: Progression Free Survival (Months)  
Figure 4: 1 month RIM 
+/- 5% PFS 
  
Figure 2: 3 Month  
RIM +/-25% PFS 
